160 related articles for article (PubMed ID: 22331136)
1. Tetramethylpyrazine potentiates arsenic trioxide activity against HL-60 cell lines.
Wu Y; Xu Y; Shen Y; Wang C; Guo G; Hu T
Braz J Med Biol Res; 2012 Mar; 45(3):187-96. PubMed ID: 22331136
[TBL] [Abstract][Full Text] [Related]
2. [Molecular mechanism of tetramethylpyrazine to induce human promyelocytic HL-60 leukemia cells differentiation].
Wu Y; Xu Y; Gu X; Hu Y; Wang C
Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):3007-11. PubMed ID: 22308692
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction.
Li H; Zhu X; Zhang Y; Xiang J; Chen H
J Exp Clin Cancer Res; 2009 Aug; 28(1):110. PubMed ID: 19664237
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ
Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743
[TBL] [Abstract][Full Text] [Related]
5. [In vitro effect of bortezomib alone or in combination with harringtonine or arsenic trioxide on proliferation and apoptosis of multidrug resistant leukemia cells].
Cai YX; Meng FY; Sun QX; Fu YB; Li L
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):737-40. PubMed ID: 19176009
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Epstein-Barr virus-encoded latent membrane protein-1 by arsenic trioxide in nasopharyngeal carcinoma cells.
Du C; Wen B; Li D; Lin Y; Zheng Y; Peng X; Hong C; Chen J; Lin W; Hong X; Xie L; Wu M
Tumori; 2006; 92(2):140-8. PubMed ID: 16724694
[TBL] [Abstract][Full Text] [Related]
7. [Effects of As2O3 on the Proliferation, Differentiation and Apoptosis of HL-60 Cells and Its Related Mechanisms].
Zhang YL; Ren JH; Cui LY; Zhang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):647-52. PubMed ID: 26117010
[TBL] [Abstract][Full Text] [Related]
8. Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide.
Wang X; Gao P; Long M; Lin F; Wei JX; Ren JH; Yan L; He T; Han Y; Zhang HZ
Med Oncol; 2011 Dec; 28(4):1225-54. PubMed ID: 20458559
[TBL] [Abstract][Full Text] [Related]
9. [Potentiation of arsenic trioxide-induced apoptosis by retinoic acid in retinoic acid sensitive and resistant HL-60 myeloid leukemia cells].
Huang X
Chin Med J (Engl); 2000 Jun; 113(6):498-501. PubMed ID: 11775865
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
[TBL] [Abstract][Full Text] [Related]
11. [Effects of As2O3 in combination with TPA on K562 cells].
Yuan FF; Zhang XH; Mi RH; Fan RH; Yin QS; Wei XD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):943-9. PubMed ID: 25130808
[TBL] [Abstract][Full Text] [Related]
12. Antitumor efficacy of DMSA modified Fe3O4 magnetic nanoparticles combined with arsenic trioxide and adriamycin in Raji cells.
Cai X; Cai X; Wang C; Chen B; Hua W; Shen F; Yu L; He Z; Shi Y; Chen Y; Xia G; Bao W; Zhang Y; Wang X
J Biomed Nanotechnol; 2014 Feb; 10(2):251-61. PubMed ID: 24738333
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
[TBL] [Abstract][Full Text] [Related]
14. In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia.
La Rosée P; Johnson K; O'Dwyer ME; Druker BJ
Exp Hematol; 2002 Jul; 30(7):729-37. PubMed ID: 12135670
[TBL] [Abstract][Full Text] [Related]
15. [Impact of arsenic trioxide on proliferation and metastasis of drug-resistant human ovarian carcinoma cell line].
Huang SG; Kong BH; Ma YY; Jiang S
Ai Zheng; 2002 Aug; 21(8):863-7. PubMed ID: 12478894
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide reduces the invasive and metastatic properties of nasopharyngeal carcinoma cells in vitro.
Du CW; Wen BG; Li DR; Peng X; Hong CQ; Chen JY; Lin ZZ; Hong X; Lin YC; Xie LX; Wu MY; Zhang H
Braz J Med Biol Res; 2006 May; 39(5):677-85. PubMed ID: 16648906
[TBL] [Abstract][Full Text] [Related]
17. [HL-60 cell apoptosis induced by bortezomib alone or in combination with arsenic trioxide in vitro].
Sun QX; Meng FY; Fu YB; Li L; Tian S
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1022-5. PubMed ID: 17666343
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle arrest and apoptotic cell death in cultured human gastric carcinoma cells mediated by arsenic trioxide.
Shao QS; Ye ZY; Ling ZQ; Ke JJ
World J Gastroenterol; 2005 Jun; 11(22):3451-6. PubMed ID: 15948253
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line.
Cui L; Zhang S; Zhang W; Hu Z; Cao Z; Li T
Oncol Res; 2010; 18(7):305-14. PubMed ID: 20377131
[TBL] [Abstract][Full Text] [Related]
20. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide.
Lin TH; Kuo HC; Chou FP; Lu FJ
BMC Cancer; 2008 Feb; 8():58. PubMed ID: 18294404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
